Impact of immune suppressive agents on the BK‐Polyomavirus non coding control region

[1]  A. Kribben,et al.  Impact of low‐level BK polyomavirus viremia on intermediate‐term renal allograft function , 2018, Transplant infectious disease : an official journal of the Transplantation Society.

[2]  J. Pascual,et al.  Recommendations for the use of everolimus in de novo kidney transplantation: False beliefs, myths and realities. , 2017, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.

[3]  J. Fishman Infection in Organ Transplantation , 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[4]  H. Walter,et al.  HIV-1 persistent viremia is frequently followed by episodes of low-level viremia , 2017, Medical Microbiology and Immunology.

[5]  H. Hirsch,et al.  Imperfect Symmetry of Sp1 and Core Promoter Sequences Regulates Early and Late Virus Gene Expression of the Bidirectional BK Polyomavirus Noncoding Control Region , 2016, Journal of Virology.

[6]  V. Nickeleit,et al.  Distinct BK polyomavirus non-coding control region (NCCR) variants in oral fluids of HIV- associated Salivary Gland Disease patients. , 2016, Virology.

[7]  H. Hirsch,et al.  BK Polyomavirus Replication in Renal Tubular Epithelial Cells Is Inhibited by Sirolimus, but Activated by Tacrolimus Through a Pathway Involving FKBP‐12 , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[8]  J. MacKeigan,et al.  Differentiating the mTOR inhibitors everolimus and sirolimus in the treatment of tuberous sclerosis complex. , 2015, Neuro-oncology.

[9]  P. Reinke,et al.  The Loss of BKV‐specific Immunity From Pretransplantation to Posttransplantation Identifies Kidney Transplant Recipients at Increased Risk of BKV Replication , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[10]  E. Sausville,et al.  Targeting of mTOR catalytic site inhibits multiple steps of the HIV-1 lifecycle and suppresses HIV-1 viremia in humanized mice , 2015, Proceedings of the National Academy of Sciences.

[11]  J. Klawitter,et al.  Everolimus and sirolimus in transplantation-related but different , 2015, Expert opinion on drug safety.

[12]  Shang-jun Jiang,et al.  Dual targeting of mTORC1 and mTORC2 by INK-128 potently inhibits human prostate cancer cell growth in vitro and in vivo , 2015, Tumor Biology.

[13]  W. Schaffner,et al.  Sp1 Sites in the Noncoding Control Region of BK Polyomavirus Are Key Regulators of Bidirectional Viral Early and Late Gene Expression , 2015, Journal of Virology.

[14]  F. Liu,et al.  The preclinical evaluation of the dual mTORC1/2 inhibitor INK-128 as a potential anti-colorectal cancer agent , 2015, Cancer biology & therapy.

[15]  J. Schaenman,et al.  BK virus infection following kidney transplantation: an overview of risk factors, screening strategies, and therapeutic interventions , 2014, Current opinion in organ transplantation.

[16]  P. Mischel,et al.  mTORC2 in the center of cancer metabolic reprogramming , 2014, Trends in Endocrinology & Metabolism.

[17]  Cheng-Huang Shen,et al.  Inhibition of BK virus replication in human kidney cells by BK virus large tumor antigen-specific shRNA delivered by JC virus-like particles. , 2014, Antiviral research.

[18]  K. Korn,et al.  BK viremia and polyomavirus nephropathy in 352 kidney transplants; risk factors and potential role of mTOR inhibition , 2013, BMC Nephrology.

[19]  C. H. Rinaldo,et al.  The human polyomavirus BK (BKPyV): virological background and clinical implications , 2013, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[20]  D. Sabatini,et al.  Regulation of mTORC1 and its impact on gene expression at a glance , 2013, Journal of Cell Science.

[21]  G. Russ,et al.  Polyomavirus BK Replication in De Novo Kidney Transplant Patients Receiving Tacrolimus or Cyclosporine: A Prospective, Randomized, Multicenter Study , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[22]  R. Drew,et al.  Phylogenetic analysis of the complete genome of 11 BKV isolates obtained from allogenic stem cell transplant recipients in Ireland , 2012, Journal of medical virology.

[23]  J. Sipley,et al.  Evaluation of a BK virus viral load assay using the QIAGEN Artus BK Virus RG PCR test. , 2012, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[24]  D. Kuypers Management of polyomavirus-associated nephropathy in renal transplant recipients , 2012, Nature Reviews Nephrology.

[25]  Nicholas T. Ingolia,et al.  The translational landscape of mTOR signalling steers cancer initiation and metastasis , 2012, Nature.

[26]  M. Radi,et al.  ATP-competitive inhibitors of mTOR: an update. , 2011, Current medicinal chemistry.

[27]  D. Muruve,et al.  Anti-BK Virus Mechanisms of Sirolimus and Leflunomide Alone and in Combination: Toward a New Therapy for BK Virus Infection , 2010, Transplantation.

[28]  K. Baggerly,et al.  Targeting of mTORC1/2 by the mTOR kinase inhibitor PP242 induces apoptosis in AML cells under conditions mimicking the bone marrow microenvironment. , 2010, Blood.

[29]  E. Major,et al.  Rearranged JC Virus Noncoding Control Regions Found in Progressive Multifocal Leukoencephalopathy Patient Samples Increase Virus Early Gene Expression and Replication Rate , 2010, Journal of Virology.

[30]  Y. S. Kim,et al.  Everolimus Plus Reduced‐Exposure CsA versus Mycophenolic Acid Plus Standard‐Exposure CsA in Renal‐Transplant Recipients , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[31]  B. O'Hara,et al.  Unique susceptibility of a human lung carcinoid tumor cell line to infection with BK virus. , 2010, Virus research.

[32]  T. Shenk,et al.  Rapamycin-Resistant mTORC1 Kinase Activity Is Required for Herpesvirus Replication , 2010, Journal of Virology.

[33]  Ethan M Balk,et al.  KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary. , 2010, Kidney international.

[34]  H. Hirsch,et al.  Functional analysis of polyomavirus BK non‐coding control region quasispecies from kidney transplant recipients , 2009, Journal of medical virology.

[35]  Hans H Hirsch,et al.  The decade of polyomavirus BK-associated nephropathy: state of affairs. , 2009, Transplantation.

[36]  C. Drachenberg,et al.  Polyomavirus BK with rearranged noncoding control region emerge in vivo in renal transplant patients and increase viral replication and cytopathology , 2008, The Journal of experimental medicine.

[37]  A. Mehrabi,et al.  Sirolimus in renal transplantation. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[38]  B. Kahan,et al.  BK Virus–Associated Nephropathy in Sirolimus-Treated Renal Transplant Patients: Incidence, Course, and Clinical Outcomes , 2007, Transplantation.

[39]  R. Frisque,et al.  Stability and Function of JC Virus Large T Antigen and T′ Proteins Are Altered by Mutation of Their Phosphorylated Threonine 125 Residues , 2006, Journal of Virology.

[40]  M. Suthanthiran,et al.  Polyomavirus-Associated Nephropathy in Renal Transplantation: Interdisciplinary Analyses and Recommendations , 2005, Transplantation.

[41]  M. Schnitzler,et al.  Incidence of BK with Tacrolimus Versus Cyclosporine and Impact of Preemptive Immunosuppression Reduction , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[42]  U. Moens,et al.  Polymorphism in the genome of non-passaged human polyomavirus BK: implications for cell tropism and the pathological role of the virus. , 2005, Virology.

[43]  J. Papadimitriou,et al.  Histological Patterns of Polyomavirus Nephropathy: Correlation with Graft Outcome and Viral Load , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[44]  Lin Chen,et al.  Transcriptional regulation by calcium, calcineurin, and NFAT. , 2003, Genes & development.

[45]  S. Finkelstein,et al.  Viral regulatory region sequence variations in kidney tissue obtained from patients with BK virus nephropathy. , 2003, Kidney international.

[46]  C. Cubitt Molecular genetics of the BK virus. , 2002, Advances in experimental medicine and biology.

[47]  M. Imperiale,et al.  Novel Mechanisms of E2F Induction by BK Virus Large-T Antigen: Requirement of Both the pRb-Binding and the J Domains , 1998, Molecular and Cellular Biology.

[48]  S. Günther,et al.  Infection of human polyomaviruses JC and BK in peripheral blood leukocytes from immunocompetent individuals. , 1994, Virology.

[49]  D. R. Dubbs,et al.  T antigen and initiation of cell DNA synthesis in a temperature-sensitive mouse line transformed by an SV40ts a mutant and in heterokaryons of the transformed cells and chick erythrocytes , 1978, Somatic cell genetics.